Skip to content

Insider · CIK 0001721173

Larkin Cristina

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

14

Companies

1

Filings

9

CIK

0001721173

Forms 4 and 5

Insider transactions

14 trades
DateCompanyValue
2022-02-01SPROSpero Therapeutics, Inc.A Award—
2022-02-01SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2021-08-26SPROSpero Therapeutics, Inc.A Award—
2021-02-01SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2020-12-16SPROSpero Therapeutics, Inc.M Exercise/Conversion+$70.8K
2020-12-16SPROSpero Therapeutics, Inc.S Sale−$228K
2020-12-16SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2020-02-03SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2019-01-02SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2018-07-05SPROSpero Therapeutics, Inc.M Exercise/Conversion+$23.6K
2018-07-05SPROSpero Therapeutics, Inc.S Sale−$70K
2018-07-05SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion—
2017-12-13SPROSpero Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2017-11-06SPROSpero Therapeutics, Inc.P Purchase+$21K

Recent filings

9

Companies

1

Address

C/O SPERO THERAPEUTICS, INC. 675 MASSACHUSETTS AVENUE, 14TH FLOOR

CAMBRIDGE, MA, 02139